Target intelligence / Profile preview

Shisa family member 4 (SHISA4)

Target
SHISA4
Molecular classification
Transmembrane protein, Scaffold/adaptor protein, Member of the Shisa family
01

Overview

Shisa family member 4 (SHISA4) is a membrane-associated protein belonging to the Shisa family, encoded by the SHISA4 gene and commonly referred to by multiple alternative names including TMEM58 and C1orf40[1][5]. SHISA4 has a predicted role as a scaffold/adaptor protein anchored in cell membranes, with several conserved cysteines following its transmembrane domain that may be lipid modified[3][4]. Functionally, SHISA4 has been implicated in the modulation of Wnt and FGF signaling pathways and may play a role in cell-surface signal transduction[2]. Notably, recent transcriptomic studies have identified SHISA4 as a biomarker for resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer, supporting its importance in drug response and patient stratification[1]. The protein's expression appears to decline with age in muscle tissue, and genetic perturbation studies are ongoing to further elucidate its biological context[2][6][7]. There are no confirmed direct drug interactions or established roles in other diseases, but its association with cancer resistance is of particular therapeutic interest.

Other names
TMEM58C1orf40Protein shisa-4Transmembrane protein 58UNQ583/PRO1153hShisa4Shisa homolog 4
02

Mechanism of action

Association with chemotherapeutic resistance: SHISA4 expression modulates cellular sensitivity to 5-fluorouracil but no direct binding/mechanism established; implicated as a transcriptomic biomarker for nonresponse

03

Biological functions

Signal modulation (may inhibit Wnt and FGF signaling)Scaffold/adaptor protein activityInvolved in membrane-associated processesBiomarker for drug resistance (particularly 5-fluorouracil in colorectal cancer)Possible role in aging-related pathways (expression declines with age in muscle)
04

Disease associations

Cancer (specifically as a predictor of resistance to 5-fluorouracil in colorectal cancer)Other disease roles currently undetermined, but studied in mouse phenotypes
05

Safety considerations

No notable safety concerns or therapeutic challenges documented; further research into its mechanism may reveal more
06

Interacting drugs

5-Fluorouracil
07

Biomarkers

Expression level is a biomarker for resistance or response to 5-fluorouracil in colorectal cancer patients (distinguishing nonresponders from responders)

Beyond the preview

Go deeper on Shisa family member 4 (SHISA4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shisa family member 4 (SHISA4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call